Over a 10-year period, METS-IR effectively predicted CV events among patients with PsA, with values greater than 2.48 at baseline conferring the greatest risk.

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

The FDA has approved the SAPIEN 3 platform, a TAVR therapy, for patients with severe aortic stenosis without symptoms.

Men with gout and obesity receiving febuxostat-based ULT were less likely to achieve SU targets and more frequently experienced disease flares.

No significant association was observed between viremia history during ART and CVD risk in a large international cohort of patients with HIV infection.

Survival outcomes have improved since 2014 among young, competitive athletes with SCA, although these improvements are mostly among White patients.

President Donald Trump has chosen Dr Casey Means, a wellness influencer and health tech entrepreneur, to be his nominee for surgeon general.

A study has found that use of the Organ Care System for heart donation after brain death has favorable post-transplantation outcomes.